Karl Omdahl

Led North Central District sales strategy and sales execution for a $50M+ companion animal portfolio across vaccines, parasiticides, therapeutics, and emerging product launches. Directed and developed a team of 10 Territory Managers with responsibility for regional growth, strategic account management, forecasting, budgeting, and market expansion. • Developed and executed sales strategies that consistently drove top-tier district performance, ranking in the Top 20% nationally for five consecutive years (2021–2025) while exceeding annual sales goals. • Led multiple high-impact product launches, including Credelio Quattro, generating $9M in launch sales, 206 new placement accounts, and 457 veterinary clinics ordering in first year. • Built a high-performance culture through field coaching, mentoring, and development, resulting in 6 representatives earning Champions Council recognition. • Directed territory optimization and strategic account planning initiatives to improve market penetration, account prioritization, and growth across the district. • Selected for multiple national leadership initiatives, including Infectious Disease/Vaccines Advisory Board Lead (2022–2025), Sales Force Effectiveness Advisory Board Lead (2026), and District Sales Training Program Lead (2026). • Developed forecasting and projection reporting tools adopted across the district management organization and helped lead customer rebate program enhancements to strengthen commercial execution and profitability. • Mentored and onboarded new District Managers while recruiting and developing top-performing sales talent across the organization. Select Performance Highlights: ¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯ • Ranked #1 of 30 Districts in Q1 2026 for new Credelio Quattro placement accounts during continued launch execution. District rankings included: o #9 of 30 districts with 101.2% to goal (2025) o Top 6 of 30 districts (2024) o Top 5 of 24 districts (2021–2023) o #3 of 24 districts (2019)

Led North Central regional sales operations for a $19M vaccines and therapeutics portfolio across multiple states, directing and developing a team of 10 sales representatives. Responsible for regional sales strategy, forecasting, distributor partnerships, talent development, and commercial execution. • Executed regional sales strategies that consistently delivered strong revenue performance, market growth, and achievement of sales objectives. • Built a high-performance culture through coaching, accountability, forecasting discipline, and strategic territory management. • Strengthened distributor partnerships and cross-functional collaboration to expand product adoption and improve commercial execution across the region. Select Performance Highlights: ¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯ • Exceeded annual sales goals in 8 of 9 years and earned three President’s Club awards (2012, 2014, 2015). • Recipient of the MVMA Outstanding Industry Representative Award and Leadership Award for contributions to the BI/Fort Dodge integration. • Developed the organization’s original sales budgeting tool to improve forecasting and financial planning capabilities. • Hired 10 Territory Managers that achieved President’s Club honors.

Managed and directed a sales force of 100 people on an interim basis. • Played a key role in sales force optimization initiatives, expanding team size by 50% to drive revenue growth. • Partnered with marketing, operations, and commercial teams to drive sales strategy and ensure business continuity across entire product portfolio.

Sold NSAID Metacam to companion animal veterinarians, as well as build and strengthen distributor relationships. • 2006- Sales of $981,000 ─ resulting in 119% growth over 2005. • Responsible for maximizing sales through authorized distributors by providing training and support for products and promotions. • Build and strengthen territory sales by developing strong relationships with veterinary professionals. • Maximize the use of Professional Service Veterinarian throughout respective territory.

Sold wellness-focused companion animal diagnostic tests and equipment to veterinarians. • Consistently exceeded sales objectives for companion animal diagnostic products and equipment, generating annual sales of up to $1.61M and achieving as high as 115% of quota. • Earned multiple performance recognitions, including President’s Club (2004) and Top Performer honors (2003). • Supported onboarding and development of new sales representatives while leading ongoing product and promotional training for distributor partners.

Sold dynamic splinting devices to Orthopedic Surgeons, Podiatrists, Occupational Therapists and Physical Therapists to increase patients’ range of motion. • Outperformed previous sales benchmarks by 113% to 242% within the first four months. • Effectively worked with insurance carriers to streamline reimbursement process and to improve reimbursement levels for Dynasplint products.